This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Takeda Vaccines, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Hetal Patel: Innovator in Zika Vaccine Development
Introduction
Hetal Patel is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of vaccine development. With a total of 3 patents to his name, Patel has focused his research on combating viral diseases, particularly the Zika virus.
Latest Patents
Patel's latest patents include innovative Zika vaccines and immunogenic compositions. These patents detail methods of using one or more antigens from the Zika virus, such as clonal isolates and non-human cell-adapted strains. The disclosures emphasize the potential for these vaccines to provide effective treatments and preventive measures against Zika virus infections.
Career Highlights
Currently, Hetal Patel is associated with Takeda Vaccines, Inc., where he continues to advance his research in vaccine technology. His work has been instrumental in developing solutions that address public health challenges posed by viral outbreaks.
Collaborations
Patel collaborates with several talented individuals in his field, including Jill Ann Livengood and Hansi Dean. These partnerships enhance the innovative capacity of his research and contribute to the development of effective vaccines.
Conclusion
Hetal Patel's work in Zika vaccine development showcases his commitment to improving global health through innovative solutions. His contributions are vital in the ongoing fight against viral diseases, and his patents reflect a promising future in vaccine research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile